LHRH-a: Luteinizing hormone-releasing hormone agonist; MRC: Medical Research Council; NCIC: National Cancer Insitute of Canada; PCSS: Prostate cancer-specific survival; PSA: Prostate-specific ...

The aim was to compare serum TST recovery between LHRH agonists and LHRH antagonists. A total of 131 patients who underwent radiation therapy with ADT for prostate cancer were retrospectively analyzed ...

LHRH-a: Luteinizing hormone-releasing hormone agonist; MRC: Medical Research Council; NCIC: National Cancer Insitute of Canada; PCSS: Prostate cancer-specific survival; PSA: Prostate-specific ...

An Ancillary Study of the STAMPEDE Docetaxel Trials Ruth Langley presented results from a phase 3 trial comparing transdermal estradiol to LHRH agonists for androgen suppression in M0 prostate cancer.

Medically reviewed by Matthew Wosnitzer, MD Castration-resistant prostate cancer (CRPC) is a type of advanced prostate cancer ...

Share on Pinterest Skipping cancer screenings may contribute to a higher mortality rate from prostate cancer, new research suggests. jamesbenet/Getty Images Men who often miss their prostate ...

Researchers are warning that men who regularly dodge prostate cancer screening appointments are 45% more likely to die from the disease. Prostate cancer is the most common cancer among men and the ...

A new at-home spit test for prostate cancer may be better than current testing methods, a new study has suggested. Experts have developed a new saliva test which analyses genetic variants in a man ...

A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer resistance to enzalutamide, a frequently used drug. The article is published ...

An at-home spit test is better at identifying prostate cancer risks in some men than the standard test on the market, a new study has found. The findings mean those at higher risk of prostate ...

I am a Forbes contributor covering travel, wellness and beauty. Prostate cancer is the second most common cancer among men in the United States, with nearly 1 in 8 men being diagnosed in their ...